KemPharm
KMPH
#8927
Rank
โ‚ฌ0.18 B
Marketcap
5,30ย โ‚ฌ
Share price
-0.34%
Change (1 day)
12.61%
Change (1 year)

Earnings for KemPharm (KMPH)

Earnings in 2022 (TTM): -โ‚ฌ40.15 Million

According to KemPharm's latest financial reports the company's current earnings are โ‚ฌ10.45 Million. In 2021 the company made an earning of -โ‚ฌ7.43 Million a decrease over its 2020 earnings that were of -โ‚ฌ5.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KemPharm from 2014 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ40.15 Million441.03%
2021 -โ‚ฌ7.43 Million39.34%
2020 -โ‚ฌ5.33 Million-67.62%
2019 -โ‚ฌ16.45 Million-63.58%
2018 -โ‚ฌ45.16 Million54.69%
2017 -โ‚ฌ29.19 Million224.53%
2016 -โ‚ฌ9 Million-79.67%
2015 -โ‚ฌ44.25 Million122.91%
2014 -โ‚ฌ19.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Theravance Biopharma
TBPH
โ‚ฌ53.73 M-240.61% Cayman Islands
Jazz Pharmaceuticals
JAZZ
โ‚ฌ0.23 B-719.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ANI Pharmaceuticals
ANIP
โ‚ฌ0.14 B-476.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚ฌ13.71 Million-64.14%๐Ÿ‡บ๐Ÿ‡ธ USA